- 1973
Eveliina tells about her TET-traineeship program at Turku Bioscience
11 Nov, 2021
On 1-5 November, we had a TET-trainee (workplace practice program for junior high school students) Eveliina Lähdesmäki at Westermarck Lab. During these five days, she got a broad overall introduction of our centre’s activities. Her schedule was packed! We asked Eveliina about the time she spent with us, what she learned and what she liked about this traineeship.
- 1973
- 1902
- 1973
- 1973
- 1973
- 1973
- 1973
- 1901
- 1973
Discovery of a Novel CIP2A Variant (NOCIVA) with clinical relevance in predicting TKI resistance in myeloid leukemias
18 Mar, 2021
Discovery of a NOCIVA in the Westermarck Research Group by Eleonora Mäkelä
- 1973
- 1973
- 1973
- 1973
- 1973
Turku Bioscience research groups successful in receiving funding from The Health from Science (TERVA) Academy Programme follow-up call
18 Sep, 2020
The Health from Science (TERVA) Academy Programme seeks bold, new research initiatives that can solve health issues related to major public health diseases. The programme highlights the importance of scientific research in solving public health challenges.
- 1973
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test
16 Sep, 2020
A recent study from Finland reports that a protein kinase called LRRK2 is hyperactive in skin samples from Parkinson’s disease patients which leads to a decrease in protein synthesis.
- 1900
University of Turku Signed a Significant Drug Development Licensing Agreement
20 Aug, 2020
The University of Turku has entered into a licensing agreement with an international pharma company related to targeting of CIP2A oncoprotein.
- 1900
Jane and Aatos Erkko Foundation Grants €1 million for Westermarck group
5 Jun, 2020
Jane and Aatos Erkko Foundation has awarded 975 000 € for research led by professor Jukka Westermarck and focused on phosphorylation mechanism under RAS oncoprotein.
- 1900
New insights into regulation of human T-cells
4 Jun, 2020
Dissertation: Kartiek Kanduri, M.Sc. 5.6.2020, medical microbiology and immunology
Kartiek Kanduri discovered several novel factors that regulate T-cell differentiation and function, Understanding the regulation of immune response is central for designing future strategies to combat immune mediated diseases.
- 1900
Easy to find Turku Bioscience
27 Apr, 2020
Now that BioCity has a brand new look, the guiding star of Turku Bioscience came up on the black wall. Now it is easier to find us, just follow the logo!
Here are a few pictures of the installation:
- 1900
JNK Protein Triggers Nerve Cells to Withdraw Their Synapses when Stressed
13 Mar, 2020
New study from Eleanor Coffey’s lab at Turku Bioscience Centre in Finland identifies that the JNK protein triggers nerve cells to withdraw their synapses when stressed.
- 1900
University of Turku Receives Significant Diabetes Research Funding from United States
24 Feb, 2020
World leading diabetes research foundation JDRF from the United States has granted the University of Turku three-year funding for its PAMP project (Pathogen Associated Molecular Patterns) with the total sum of over €520,000.
- 1900
- 1900
Top Experts in Light Microscopy to Meet in Turku in 2021
27 Jan, 2020
The 2021 International European Light Microscopy Initiative (ELMI) conference has been decided to be organised in Turku. The conference welcomes research centres providing light microscopy services and equipment, as well as companies in the field from Europe and elsewhere around the world to Turku.
- 1900
- 1900
Chronic Enteroviral Infection Modifies Broadly Pancreatic Cellular Functions
10 Sep, 2019
Enteroviral infections are common viral infections with usually rather few symptoms, and they are also believed to be linked to the onset of type 1 diabetes. Type 1 diabetes is a disorder in which the pancreatic insulin-producing beta-cells are destroyed, and it is more common in Finland than anywhere else in the world. A new study by the University of Turku and Tampere University supports the link between enteroviral infections and type 1 diabetes.
- 1900
Researchers from Turku Bioscience Centre Identified Novel Oncogenic Function for Receptor Linked with Alzheimer’s Disease
28 May, 2019
Common and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer’s disease. So far, SORLA has been mainly studied in neurons, but the new study focused on the role of SORLA in cancer cells. Led by Academy Professor Johanna Ivaska, the research group observed that SORLA was highly expressed in HER2 positive cancers. Removing SORLA from cancer cells severely impaired the oncogenic fitness of HER2 positive cancers.
- 1900
- 1900
Inspiring and thoughtful discussion on cancer
28 Apr, 2019
Academy Professor Johanna Ivaska was invited to the popular talk-show Flinkkilä & Tastula to discuss cancer research together with the stand-up comedian Anitta Ahonen, who was diagnosed with cancer three years ago.
- 1900
The new name of Turku Bioscience and its 30 year anniversary gets wide publicity
25 Apr, 2019
The anniversary of Turku Bioscience and its anniversary was highlighted in all local media yesterday and today.
- 1900
Four new Academy of Finland postdoctoral researcher positions to Turku Bioscience
23 Apr, 2019
Turku Bioscience proudly presents four new post doctoral fellows
- 1905
Laura Elo Receives the Rising Talent Award of the For Women in Science Programme
8 Mar, 2019
Research Director Laura Elo from Turku Centre for Biotechnology receives the international Rising Talent Award of the For Women in Science programme granted by the L’Oréal Foundation and UNESCO. The recognition is awarded to 15 most promising women researchers from all over the world. The recognition is awarded on Thursday, 14 March in Paris.
- 1900
Researchers Discovered New Immune Response Regulators
15 Jan, 2019
The research groups of Academy Professor Riitta Lahesmaa and Research Director Laura Elo from Turku Centre for Biotechnology have discovered new proteins that regulate T cells in the human immune system. Some of these proteins can provide possible new targets for drug development in treating immune-mediated diseases.
- 1900
- 1900
Finnish Medical Foundation awarded €150,000 to CBT´s affiliated group leader Sami Ventelä
22 Nov, 2018
Finnish Medical Foundation awarded Research Group Founder Grant of €150,000 to Clinical Lecturer at the University of Turku, Specialist in Otorhinolaryngology, MD Sami Ventelä. Ventelä is also a new Affiliated Group Leader at Turku Centre for Biotechnology.
- 1900
Syöpäsolujen hoitovastetta määrittävän jarrumekanismin tutkimukselle Syöpäsäätiön suurapuraha (In Finnish only)
14 Nov, 2018
Syöpäsäätiö on myöntänyt 450 000 euron suurapurahan Turun yliopiston kolmevuotiselle tutkimushankkeelle, jonka tavoitteena on selvittää syöpäsolun sisäisiä mekanismeja rintasyövässä ja pahanlaatuisessa aivosyövässä.
- 1900
New Mathematical Model Predicts Respiratory Viral Infection Symptoms Severity
5 Nov, 2018
A team from the University of Turku has developed a mathematical model that predicts which patients become symptomatic after viral exposure using gene expression levels in blood prior to exposure.
- 1900
- 1900
- 1900
News and Events
No menu selected
